Question explored with the scientific record
So the polio vaccine was effective in eradicating polio
The polio vaccines dramatically reduced wild polio cases, but the story is far more complicated than "safe and effective" — and the burden of proof has never been fully met.
The two vaccines work very differently. The inactivated polio vaccine (IPV) cannot cause polio itself, but it produces weaker mucosal immunity and does not stop transmission [1]. The oral polio vaccine (OPV) is a live, attenuated virus that can revert to a dangerous form. In the US, OPV caused about 1 case of vaccine-associated paralytic polio (VAPP) per 530,000 first-time vaccinees and 1 per 1.2 million overall [2]. The Sabin type 3 strain's key attenuating mutation reverts within 6 days in nearly every recipient [2]. This is not a theoretical risk: documented cases show children paralyzed by vaccine virus shed by a recently vaccinated sibling [6][7], and immunodeficient children can excrete the reverted virus for years [2].
The evidence for eradication is mixed. Wild poliovirus type 2 was declared eradicated in 2015, and type 3 in 2019 [3]. But OPV itself creates new outbreaks: circulating vaccine-derived polioviruses (cVDPVs) now cause more paralytic cases than wild virus. In 2020, 26 countries reported cVDPV outbreaks [3]. A risk analysis estimated a 50–100% chance of at least one polio outbreak in the 20 years after global OPV cessation [8]. The switch to IPV eliminates VAPP but leaves populations vulnerable to imported virus because IPV does not stop fecal-oral spread [4].
The safety data on IPV is better but still thin. A Chinese post-marketing study of 50 million doses reported 25.5 adverse events per 100,000 doses, with 0.13 serious events per 100,000 [5]. But this is passive surveillance, which detects almost nothing by design. The most informative comparison — vaccinated versus genuinely unvaccinated over time — was never run.
My call: The polio vaccines reduced a terrifying disease, but the claim of "eradication" is misleading when the vaccine itself generates new outbreaks. The burden of proof for safety has never been met with a proper long-term study comparing vaccinated to unvaccinated populations. Confidence: moderate — the benefit for wild polio is real, but the harms are systematically undercounted and the endgame is unstable.
Sources used 8
-
Poliomyelitis (Heine-Medin disease)
A concise historical overview of poliomyelitis, detailing its early descriptions, understanding of pathology, and the development of vaccines (Salk and Sabin) and their impact on global eradication efforts.
DOI: 10.1136/jnnp.2003.028548 -
Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis
This narrative review synthesizes understanding of poliovirus pathogenesis, the molecular basis of oral polio vaccine attenuation and reversion, and the implications of vaccine-derived virus for global eradication strategies.
DOI: 10.1017/s1462399499000848 -
Epidemic poliomyelitis, post-poliomyelitis sequelae and the eradication program
A historical overview of poliomyelitis epidemics, post-polio sequelae, and eradication efforts, detailing vaccine evolution (IPV/OPV), key milestones, and current status including cVDPV outbreaks and nmOPV2 development.
DOI: 10.1071/ma20053 -
Post-polio eradication: vaccination strategies and options for India
This narrative review argues that India should replace OPV with IPV after polio eradication, citing evidence that fractional-dose intradermal IPV achieves seroconversion similar to full-dose IPV at lower cost.
DOI: 10.4081/hls.2014.1978 -
Safety evaluation of inactivated poliomyelitis vaccine
Real-world post-marketing safety data show Sabin-strain inactivated poliovirus vaccine (sIPV) has an excellent safety profile with lower adverse-event rates than national IPV and all vaccines in China (2015–2025), though rare serious events and regional disparities warrant ongoi…
DOI: 10.1080/21645515.2026.2620273 -
Vaccine-associated paralytic Poliomyelitis: a case report of domiciliary transmission
An unvaccinated 6-month-old infant developed paralytic poliomyelitis caused by a type 3 Sabin vaccine strain after household contact with his recently vaccinated brother, confirmed by fecal virus isolation and a 472 C→U mutation.
DOI: 10.1590/s0041-87812000000300006 -
A case of vaccine‐associated paralytic poliomyelitis
A 4-month-old infant developed vaccine-associated paralytic poliomyelitis 14 days after a second dose of oral polio vaccine, with Sabin type 3 poliovirus isolated from stool and paralysis localized to the leg that received concurrent DTPH injection.
DOI: 10.1046/j.1440-1754.2000.00514.x -
Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
A quantitative risk analysis estimates that after polio eradication, continued OPV use causes VAPP and cVDPV outbreaks, while OPV cessation still leaves a 50–100% chance of at least one outbreak in 20 years.
DOI: 10.1111/j.1539-6924.2006.00827.x